Rapport Therapeutics, Inc. Common Stock ( RAPP) - Key Metrics
RAPP Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$1.19 | -$0.87 | -$0.87 |
| 2026Q1 | $0.42 | -$0.42 | -$0.28 | -$0.28 |
| 2025Q4 | $0 | -$0.72 | -$0.53 | -$0.53 |
| 2025Q3 | $0 | -$0.71 | -$0.46 | -$0.46 |
| 2025Q2 | $0 | -$0.75 | -$0.71 | -$0.71 |
RAPP Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -8.75 |
| 2026Q1 | 0% | -18.63 |
| 2025Q4 | 0% | -10.53 |
| 2025Q3 | 0% | -10.46 |
| 2025Q2 | 0% | -3.79 |
RAPP
Price: $48.26
52 week price:
Earnings Per Share: -2.96 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 2.3 billion